1. Home
  2. PGEN vs BLNK Comparison

PGEN vs BLNK Comparison

Compare PGEN & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • BLNK
  • Stock Information
  • Founded
  • PGEN 1998
  • BLNK 2009
  • Country
  • PGEN United States
  • BLNK United States
  • Employees
  • PGEN N/A
  • BLNK N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • BLNK Industrial Specialties
  • Sector
  • PGEN Health Care
  • BLNK Consumer Discretionary
  • Exchange
  • PGEN Nasdaq
  • BLNK Nasdaq
  • Market Cap
  • PGEN 292.6M
  • BLNK 295.1M
  • IPO Year
  • PGEN N/A
  • BLNK N/A
  • Fundamental
  • Price
  • PGEN $0.91
  • BLNK $1.56
  • Analyst Decision
  • PGEN Buy
  • BLNK Buy
  • Analyst Count
  • PGEN 5
  • BLNK 7
  • Target Price
  • PGEN $7.00
  • BLNK $5.64
  • AVG Volume (30 Days)
  • PGEN 915.1K
  • BLNK 5.4M
  • Earning Date
  • PGEN 11-14-2024
  • BLNK 11-07-2024
  • Dividend Yield
  • PGEN N/A
  • BLNK N/A
  • EPS Growth
  • PGEN N/A
  • BLNK N/A
  • EPS
  • PGEN N/A
  • BLNK N/A
  • Revenue
  • PGEN $3,963,000.00
  • BLNK $138,728,000.00
  • Revenue This Year
  • PGEN N/A
  • BLNK N/A
  • Revenue Next Year
  • PGEN $426.76
  • BLNK $24.35
  • P/E Ratio
  • PGEN N/A
  • BLNK N/A
  • Revenue Growth
  • PGEN N/A
  • BLNK 15.13
  • 52 Week Low
  • PGEN $0.77
  • BLNK $1.48
  • 52 Week High
  • PGEN $1.93
  • BLNK $4.48
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 50.79
  • BLNK 40.86
  • Support Level
  • PGEN $0.84
  • BLNK $1.53
  • Resistance Level
  • PGEN $0.97
  • BLNK $1.70
  • Average True Range (ATR)
  • PGEN 0.07
  • BLNK 0.09
  • MACD
  • PGEN 0.01
  • BLNK 0.00
  • Stochastic Oscillator
  • PGEN 64.95
  • BLNK 22.06

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.

Share on Social Networks: